Parathyroidectomy enhances the nephrotoxicity of gentamicin

Detalhes bibliográficos
Autor(a) principal: Glashan, Regiane Q. [UNIFESP]
Data de Publicação: 1997
Outros Autores: Silva, Vera Lidia Costa [UNIFESP], Cavanal, Maria de Fátima [UNIFESP], Gil, Frida Zaladek [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/25706
http://dx.doi.org/10.1016/S0011-393X(97)80023-9
Resumo: The objective of this study was to evaluate the effect of parathyroidectomy on the renal function in rats treated with saline (control), low-dose gentamicin (GM, 4 mg/kg per day), or high-dose GM (40 mg/kg per day) for 10 consecutive days. Gentamicin sulfate was dissolved in saline. A group of rats were subjected to thyroparathyroidectomy (PTX) 2 to 3 days before the beginning of the GM treatment. Thyroxine (1 mu g/100 g body weight) was subcutaneously injected daily into PTX rats. in rats with saline infusion, a significant reduction in renal functional variables was obtained after PTX. When GM treatment and PTX were both present, a further impairment in the glomerular filtration rate and the urine/plasma inulin ratio was observed, suggesting additive effects. in rats infused with ammonium chloride to cause metabolic acidosis, a decline in glomerular filtration rate was obtained, a condition that was aggravated when GM treatment and PTX were both present. Acid excretion was significantly reduced in PTX groups, mainly during acidosis. in acidotic PTX rats treated with both low and high GM doses, the excreted amount of acid was strongly impaired, compared with the acidotic non-PTX GM group. These results show that in the PTX rats nephrotoxicity of GM is increased, which suggests that in this experimental model, parathyroid hormone may exert a protective effect during aminoglycoside treatment.
id UFSP_6416542015416f457031fb601153b890
oai_identifier_str oai:repositorio.unifesp.br:11600/25706
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Glashan, Regiane Q. [UNIFESP]Silva, Vera Lidia Costa [UNIFESP]Cavanal, Maria de Fátima [UNIFESP]Gil, Frida Zaladek [UNIFESP]Universidade Federal de São Paulo (UNIFESP)2016-01-24T12:30:19Z2016-01-24T12:30:19Z1997-04-01Current Therapeutic Research-clinical and Experimental. New York: Excerpta Medica Inc, v. 58, n. 4, p. 272-280, 1997.0011-393Xhttp://repositorio.unifesp.br/handle/11600/25706http://dx.doi.org/10.1016/S0011-393X(97)80023-910.1016/S0011-393X(97)80023-9WOS:A1997WV34700007The objective of this study was to evaluate the effect of parathyroidectomy on the renal function in rats treated with saline (control), low-dose gentamicin (GM, 4 mg/kg per day), or high-dose GM (40 mg/kg per day) for 10 consecutive days. Gentamicin sulfate was dissolved in saline. A group of rats were subjected to thyroparathyroidectomy (PTX) 2 to 3 days before the beginning of the GM treatment. Thyroxine (1 mu g/100 g body weight) was subcutaneously injected daily into PTX rats. in rats with saline infusion, a significant reduction in renal functional variables was obtained after PTX. When GM treatment and PTX were both present, a further impairment in the glomerular filtration rate and the urine/plasma inulin ratio was observed, suggesting additive effects. in rats infused with ammonium chloride to cause metabolic acidosis, a decline in glomerular filtration rate was obtained, a condition that was aggravated when GM treatment and PTX were both present. Acid excretion was significantly reduced in PTX groups, mainly during acidosis. in acidotic PTX rats treated with both low and high GM doses, the excreted amount of acid was strongly impaired, compared with the acidotic non-PTX GM group. These results show that in the PTX rats nephrotoxicity of GM is increased, which suggests that in this experimental model, parathyroid hormone may exert a protective effect during aminoglycoside treatment.Universidade Federal de São Paulo,ESCOLA PAULISTA MED,DEPT PHYSIOL,São Paulo,BRAZILUniversidade Federal de São Paulo,ESCOLA PAULISTA MED,DEPT PHYSIOL,São Paulo,BRAZILWeb of Science272-280engExcerpta Medica IncCurrent Therapeutic Research-clinical and Experimentalgentamicinnephrotoxicityparathyroid hormoneacid excretionParathyroidectomy enhances the nephrotoxicity of gentamicininfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP11600/257062022-02-18 10:09:39.938metadata only accessoai:repositorio.unifesp.br:11600/25706Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652022-02-18T13:09:39Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Parathyroidectomy enhances the nephrotoxicity of gentamicin
title Parathyroidectomy enhances the nephrotoxicity of gentamicin
spellingShingle Parathyroidectomy enhances the nephrotoxicity of gentamicin
Glashan, Regiane Q. [UNIFESP]
gentamicin
nephrotoxicity
parathyroid hormone
acid excretion
title_short Parathyroidectomy enhances the nephrotoxicity of gentamicin
title_full Parathyroidectomy enhances the nephrotoxicity of gentamicin
title_fullStr Parathyroidectomy enhances the nephrotoxicity of gentamicin
title_full_unstemmed Parathyroidectomy enhances the nephrotoxicity of gentamicin
title_sort Parathyroidectomy enhances the nephrotoxicity of gentamicin
author Glashan, Regiane Q. [UNIFESP]
author_facet Glashan, Regiane Q. [UNIFESP]
Silva, Vera Lidia Costa [UNIFESP]
Cavanal, Maria de Fátima [UNIFESP]
Gil, Frida Zaladek [UNIFESP]
author_role author
author2 Silva, Vera Lidia Costa [UNIFESP]
Cavanal, Maria de Fátima [UNIFESP]
Gil, Frida Zaladek [UNIFESP]
author2_role author
author
author
dc.contributor.institution.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Glashan, Regiane Q. [UNIFESP]
Silva, Vera Lidia Costa [UNIFESP]
Cavanal, Maria de Fátima [UNIFESP]
Gil, Frida Zaladek [UNIFESP]
dc.subject.eng.fl_str_mv gentamicin
nephrotoxicity
parathyroid hormone
acid excretion
topic gentamicin
nephrotoxicity
parathyroid hormone
acid excretion
description The objective of this study was to evaluate the effect of parathyroidectomy on the renal function in rats treated with saline (control), low-dose gentamicin (GM, 4 mg/kg per day), or high-dose GM (40 mg/kg per day) for 10 consecutive days. Gentamicin sulfate was dissolved in saline. A group of rats were subjected to thyroparathyroidectomy (PTX) 2 to 3 days before the beginning of the GM treatment. Thyroxine (1 mu g/100 g body weight) was subcutaneously injected daily into PTX rats. in rats with saline infusion, a significant reduction in renal functional variables was obtained after PTX. When GM treatment and PTX were both present, a further impairment in the glomerular filtration rate and the urine/plasma inulin ratio was observed, suggesting additive effects. in rats infused with ammonium chloride to cause metabolic acidosis, a decline in glomerular filtration rate was obtained, a condition that was aggravated when GM treatment and PTX were both present. Acid excretion was significantly reduced in PTX groups, mainly during acidosis. in acidotic PTX rats treated with both low and high GM doses, the excreted amount of acid was strongly impaired, compared with the acidotic non-PTX GM group. These results show that in the PTX rats nephrotoxicity of GM is increased, which suggests that in this experimental model, parathyroid hormone may exert a protective effect during aminoglycoside treatment.
publishDate 1997
dc.date.issued.fl_str_mv 1997-04-01
dc.date.accessioned.fl_str_mv 2016-01-24T12:30:19Z
dc.date.available.fl_str_mv 2016-01-24T12:30:19Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Current Therapeutic Research-clinical and Experimental. New York: Excerpta Medica Inc, v. 58, n. 4, p. 272-280, 1997.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/25706
http://dx.doi.org/10.1016/S0011-393X(97)80023-9
dc.identifier.issn.none.fl_str_mv 0011-393X
dc.identifier.doi.none.fl_str_mv 10.1016/S0011-393X(97)80023-9
dc.identifier.wos.none.fl_str_mv WOS:A1997WV34700007
identifier_str_mv Current Therapeutic Research-clinical and Experimental. New York: Excerpta Medica Inc, v. 58, n. 4, p. 272-280, 1997.
0011-393X
10.1016/S0011-393X(97)80023-9
WOS:A1997WV34700007
url http://repositorio.unifesp.br/handle/11600/25706
http://dx.doi.org/10.1016/S0011-393X(97)80023-9
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Current Therapeutic Research-clinical and Experimental
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 272-280
dc.publisher.none.fl_str_mv Excerpta Medica Inc
publisher.none.fl_str_mv Excerpta Medica Inc
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764105894854656